Impact of early versus conventional kidney replacement therapy initiation in tumor lysis syndrome: a target trial emulation by Justine Serre, Guillaume Mulier, Charlotte Boud’hors, Marie Lemerle, Moustafa Abdel-Nabey, Corentin Orvain, Anis Chaba, Lucie Biard, Julien Demiselle, Lara Zafrani

Get full text

Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis by Sara Villar, Emmanuel Curis, Marie-Hélène Schlageter, Nelly Bosselut, Amandine Charbonnier, Marie-Thérèse Rubio, Pascal Turlure, Hélène Labussière, Jacques-Olivier Bay, Jérome Cornillon, Laure Vincent, Corentin Orvain, Jean-Jacques Kiladjian, David Michonneau, Gérard Socié, Marie Robin

Get full text

Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study by Jules Higué, Corentin Orvain, Pierre-Yves Dumas, Pierre Peterlin, Marie-Anne Hospital, Sabrina Barrière, Audrey Couturier, Martin Carre, Areti Chantzi, Emmanuelle Tavernier, Éric Delabesse, Audrey Bidet, Anne Bouvier, Marie-Joelle Mozziconacci, Lauren Véronèse, Cédric Pastoret, Sylvie Tondeur, Pascale Flandrin-Gresta, Sébastien Lachot, Marine Cazaux, Sylvain Thépot, Edouard Forcade, Patrice Chevallier, Raynier Devillier, Gaspar Aspas Requena, Sarah Bertoli, Arnaud Pigneux, Christian Récher

Get full text